The FDA extended indications for nivolumab (Opdivo) to include treatment of advanced (metastatic) renal cell carcinoma (RCC).
S-1 is just as effective in terms of overall survival as a taxane as first-line treatment for patients with metastatic breast cancer.
Nanoliposomal irinotecan in combination with fluorouracil and folinic acid improves survival in patients with pancreatic ductal adenocarcinoma.
Both in-person and telephone counseling were effective weight loss strategies in breast cancer survivors and resulted in favorable effects.
The use of anastrozole for the prevention of breast cancer was associated with a higher incidence of carpal tunnel syndrome (CTS).
Overall screening colonoscopy rate in New York City got a boost from a concerted effort to increase colorectal cancer screening rates.
Survivors of the 10 most common cancers diagnosed in adolescents and young adults (AYAs) are at considerably higher risk for diseases.
Patients who are undergoing radiotherapy for prostate cancer may benefit from yoga.
TESARO Inc has announced that rolapitant (Varubi), a neurokinin-1 (NK-1) receptor antagonist, is now available in the United States.
Herpes zoster (HZ) is associated with a modestly increased risk of several cancers, particularly hematologic malignancies.
Survival for follicular lymphoma and diffuse large B-cell lymphoma is improving in Europe.
Survivors of Hodgkin lymphoma have an increased risk for developing various late complications, including cardiovascular disease.
Depression and antidepressant use may not be associated with increased risk of breast cancer.
Both the incidence of early stage prostate cancer and rates of prostate-specific antigen (PSA) screening oincide with the 2012 USPSTF recommendation.
Androgen deprivation therapy is associated with declines in self-reported physical functioning and upper body muscle strength.
Late effect of Hodgkin lymphoma (HL) treatment is a 2.5-fold increased risk of coronary heart disease (CHD) in survivors.
Use of initial palliative chemotherapy for patients with hormone receptor positive breast cancer is associated with poorer outcomes.
Prophylactic minocycline and reactive treatment are both acceptable options for treatment of erlotinib-induced rash in non-small cell lung cancer (NSCLC).
Women receiving chemotherapy for breast cancer have a clinical important risk for developing venous thromboemboli (VTE).
Oncology care providers should develop interventions that remind and encourage them to have physical activity communications.
Extent of atypical ductal hyperplasia (ADH) or atypical lobular hyperplasia (ALH) does not significantly contribute to breast cancer risk.
The likelihood of patients with early stage non-small cell lung cancer (NSCLC) undergoing curative-intent surgery varies.
A healthy diet may reduce the risk for developing ovarian cancer in African American women.
Disparities in colorectal cancer (CRC) death rates take a large toll on the United States economy.
A contributor to persistent racial/ethnic and socioeconomic disparities is limited understanding of the care provided to minority populations.
Rates of some adverse events are significantly higher for these patients.
Lenalidomide plus rituximab produced durable and long-term responses in previously untreated patients with mantle cell lymphoma.
Patients who develop ovarian cancer may have improved outcomes if they have prior oral contraceptive use.
Researchers from the Dana-Farber Cancer Institute are calling for hospitals to establish bereavement programs for families of deceased patients.
A recent study recommends clinicians use caution when prescribing drugs for off-label uses that lack strong scientific evidence.
Results from a phase 1 clinical trial suggest that pevonedistat is safe, tolerable, and has some anticancer activity.
A new first-of-its-kind mobile app called Breast Cancer Ally serves as a treatment navigator for patients with breast cancer receiving care.
Sorafenib increases progression-free survival, time to progression, and disease control rate in patients with non-small cell lung cancer (NSCLC).
A recent study has linked an increased risk of kidney cancer to certain meat-cooking mutagens.
Venlafaxine has a significant clinical activity against taxane-oxaliplatin-induced acute neurosensory toxicity in patients with cancer.
Weekly carboplatin in combination with weekly paclitaxel results in good response rates in non-small cell lung cancer (NSCLC).
Similar rates of recommended processes of diabetes care were observed for both nurse practitioners and primary care physicians, according to a recent study.
Cancer survivors who disclose their health history in a job interview are less likely to receive callbacks from potential retail employers.
Good patient-provider communication is associated with lower levels of lung cancer stigma.
Adding aprepitant to palonosetron and dexamethasone provided no improvement in carboplatin-induced emesis in non-small cell lung cancer (NSCLC).
Suggestions for controls include price controls on drugs, hospitals, and doctors.
For veterans with early-stage prostate cancer, patient age and tumor risk were found to be more strongly associated with use of expectant management.
The new EHR regulations modify Stage 2 of meaningful use program and finalize requirements for Stage 3.
Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer.
Patients with advanced breast cancer who have higher insulin levels have a significantly worse prognosis than those with normal insulin levels.
Bosutinib continues to demonstrate durable long-term efficacy and manageable toxicity in patients with chronic myeloid leukemia (CML).
In a recent announcement, Medicare stated that it will begin reimbursing doctors who work with patients to plan end-of-life care.
Cognitive impairment is substantially greater in patients with colorectal cancer (CRC) than in healthy persons.
Both surgery and definitive concurrent chemoradiotherapy boost are acceptable treatment strategies for non-small cell lung cancer (NSCLC).
Bendamustine plus rituximab is an effective therapy with manageable toxicity in patients with relapsed/refractory mantle cell lymphoma.
Metastasizing cells undergo metabolic changes, increasing their ability to withstand oxidative stress.
Risk of basal cell carcinoma is increased in women who use menopausal hormone therapy. In addition, this risk may be higher with longer use and for women who experience natural menopause at a late age.
Simply standing a portion of the day can reduce the risk of obesity, and thereby reduce the risk of many cancers as well.
The American Society of Clinical Oncology has updated their antiemetics guideline regarding the use of netupitant and palonosetron for nausea.
Almost 4 percent of all adult Americans use e-cigarettes, a new survey shows, but use is highest among those in the 18- to 24-year age bracket.
A high response rate was seen among patients whose metastatic castration-resistant prostate cancers had DNA-repair defects.
Cancer survivors may face challenges to workplace accommodations, such as fear of requesting accommodations.
Internal mammary lymph nodes (IMLNs) identified at implant-protocol breast magnetic resonance imaging (MRI) are more likely to be benign than malignant.
High-intensity exercise training appears to be safe and efficacious to improve fitness and body composition for colorectal cancer survivors.
Patients with advanced cancers who took methylnaltrexone (Relistor) lived longer and had fewer reports of tumor progression.
Physicians failing to recommend it or adequately explain its benefits to parents could be a factor.
Elderly cancer survivors with high self-efficacy for performing strength and endurance exercise may benefit from home-based lifestyle counseling.
Regular physical activity could allow women at high-risk of developing breast cancer to delay drastic preventive measures.
Risks for cancer and cardiovascular disease are higher among people with sedentary lifestyles.
Ramosetron plus dexamethasone and aprepitant is as effective and tolerable as ondansetron.
Breast cancer rates among African American women have increased to the point that they are converging with rates among white women.
Patients with a history of skin cancer may be at an increased risk for a second nonmelanoma skin cancer with the use of methotrexate.
Better sleep quality and lower work stress has been observed for nurses in a yoga group versus non-yoga group.
Talimogene laherparapvec (Imlygic) is the first FDA-approved oncolytic virus therapy.
Researchers have found weak evidence supporting an effect of secondhand tobacco smoke exposure on the incidence of lung adenocarcinoma.
Brentuximab vedotin can normalize positron emission tomography (PET) status in a subset of patients with Hodgkin lymphoma.
Ductal Carcinoma (DCIS) is more likely to become invasive in people over 60 years old.
A sizable minority of doctors does not strongly endorse HPV vaccination nor deliver timely recommendations.
The detection rate of ductal carcinoma in situ (DCIS) on mammography increases with age.
Persons classified as obese are at the greatest risk for developing colorectal cancer.
Zarxio (filgrastim-sndz), a biosimilar of filgrastim, is efficient and well tolerated for the prophylaxis of chemotherapy-induced neutropenia.
Ever breastfeeding may provide a protective effect against hormone receptor (HR)-negative breast cancers.
Increased survival for chemoradiotherapy versus chemotherapy in limited-stage, small-cell lung cancer was observed in a recent study.
As more people survive cancer, economic hardship and employment potential are becoming significant issues for survivors.
The FDA has approved trabectedin (Yondelis) for treatment of unresectable or metastatic soft tissue sarcoma.
The consumption of processed meat, including hot dogs, ham, sausages, corned beef, and beef jerky, is carcinogenic to humans.
Generally, indigenous cancer rates are lower, except for lung cancer in men and cervical cancer in women.
Black patients treated with radical prostatectomy for localized prostate cancer (PCa) are more likely to experience adverse events.
Breast radiologist-provided direct public lectures may decrease anxiety and improve knowledge regarding breast cancer screening mammography.
Findings suggest doctors shouldn't automatically rule out less invasive surgery plus radiation for some larger breast tumors.
A new drug for the treatment of advanced (metastatic) pancreatic cancer received FDA approval.
High dose rate exposures to ionizing radiation are thought to be more dangerous than low dose rate exposures.
Survival for women with advanced ovarian cancer may be negatively impacted when chemotherapy is initiated more than 25 days after surgery.
No reduction in risk of distant metastasis, cancer-related deaths, radiation-linked adverse effects were connected to the use of men's health supplements (MHSs).
A cool pad pillow topper may be useful as an aid to reduce sleep disturbance and frequency and severity of hot flushes.
Cancer-related cognitive impairments in patients receiving adjuvant chemotherapy may be associated with under-recruitment of brain regions.
Cancer trial participation decreases with decreasing annual household income, according to recent data.
The American Cancer Society (ACS) released its updated guidelines for breast cancer screening in women at average risk for developing the disease.
The FDA has granted accelerated approval to idarucizumab (Praxbind) for the treatment of patients treated with dabigatran (Pradaxa).
Preteen girls with a family history of breast cancer seem to have similar levels of general anxiety.
Health outcomes and quality of life for informal caregivers of patients with cancer are influenced by social and family factors.
A recent study examined the impact of a nationwide skin cancer screening program started in Germany in 2008.
Potential benefits of recommending low-dose computed tomography (LDCT) lung cancer screening for 20- to 29-pack-year smokers should be evaluated.
Nearly half of patients who undergo low-dose computed tomography lung cancer screening experience heightened levels of distress.
Findings based on small study of childhood cancer survivors with treatment-related deficits shows benefits of computerized cognitive intervention.
- Blood Test Indicates Breast Cancer Tumors Developed Resistance to Hormone Treatment
- Breakthrough Advance Announced in International Blood Cancer Drug Trial
- Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
- Yoga May Reduce Side Effects in Patients Receiving Treatment for Prostate Cancer
- Existing Drug May Limit Recurrence and Metastasis of Glioblastoma Multiforme
- Breastfeeding Associated With A Reduced Risk of Aggressive Breast Cancer
- Hospitals Should Enact Bereavement Programs, Researchers Urge
- Physical Activity Communications Should be Part of Oncology Care Clinic Visits With Patients
- Communication Practices of Many US Physicians May Be Discouraging HPV Vaccination
- Chemo, Tamoxifen May Increase VTE Risk Among Patients With Breast Cancer
- Protein Biomarker Assays for Diagnosing Thyroid Cancer May Show Inaccurate Readings
- Cancer Prehabilitation and Rehabilitation: What Will It Take for These Services to Catch On?
- New Model for Breast Cancer Risk in Hispanic Women Is the First to be Based Exclusively on Data From Hispanic Women
- Blood Sample New Way of Detecting Cancer
- Liquid Biopsy of Cerebrospinal Fluid More Effective in Managing Brain Tumors
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|